Bioanalysis, biomarker assay development, validation and sample analysis.
Drug development and manufacturing for biologics and small molecules, with integrated services from preclinical, clinical to commercial.
Best-in-class drug discovery products and services to identify and develop life-changing therapies.
Global insourcing solutions delivering on-site scientific and laboratory services.
Delivering safety, efficacy, biomarker, and pathology services, through a global network of CAP accredited laboratories.
Solutions from discovery through commercialisation.
With facilities in Europe, North America and Asia, we support clients in the pharma, diagnostics, food, agriculture, biotechnological and research markets.
Comprehensive BioPharma Product Testing: a leader in testing biologics, CGT, nucleic acid therapies, and small molecules from early developm…
With over 40 years of expertise and capabilities, Eurofins Medical Device Services offers comprehensive solutions across the entire medical…
Davide Angelini, E&L and Packaging Testing Project Leader, DavideAngelini@eurofins.com; Simone Carrara, Business Unit Manager / E&L and Packaging Testing Senior Scientific Director, SimoneCarrara@eurofins.com; BioPharma Product Testing
Screening materials and medical products for compounds that may present a risk to health and safety is precisely what Extractables and Leachables (E&L) testing delivers.
Nevertheless, the system under testing is often complex enough to ensure that a different “blend” of compounds will emerge, resulting in a degree of uncertainty during the identification process.
The recurrence of tested items allows recovering of previous characterisation, increasing the efficiency of the identification workflow, reducing errors, and improving the skills of the team. This is crucial when aiming for continuous improvement and easier data sharing between those involved in the process. This makes the accumulated experience one of the most valuable assets in E&L testing, especially for the HPLC/Q-TOF technique, based on hundreds of characterisation studies and resulting in a considerable amount of extractable profile data. The challenge became: how do we manage these large data and ensure that the relevant information is quickly available when needed?
A collaboration between Eurofins BioPharma Product Testing Italy and The Visual Agency s.r.l., a web design data-driven company based in Milan, resulted in a novel tool for E&L identification, the Extractables LC/MS Search Engine or ELSE – a customised web application that allows rapid search of LC/MS results among hundreds of studies performed over the years. Filtering by exact mass, retention time and polarity, ELSE points directly to the relevant information while optional parameters can be used to refine the search. This new tool available for the Eurofins E&L teams strengthens the characterisation capabilities, helping customers reach their goal of achieving the ‘total compounds identification scenario’ requested nowadays by the regulatory bodies in the E&L studies.